Chemical Works of Gedeon Richter Plc (RGEDF)
41.20
+0.76
(+1.87%)
USD |
OTCM |
Oct 26, 16:00
Chemical Works of Gedeon Richter Price to Book Value : 1.727 for Oct. 26, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 1.727 |
| October 23, 2026 | 1.696 |
| October 22, 2026 | 1.653 |
| October 21, 2026 | 1.653 |
| October 20, 2026 | 1.670 |
| October 19, 2026 | 1.662 |
| October 16, 2026 | 1.644 |
| October 15, 2026 | 1.620 |
| October 14, 2026 | 1.593 |
| October 13, 2026 | 1.616 |
| October 12, 2026 | 1.609 |
| October 09, 2026 | 1.557 |
| October 08, 2026 | 1.499 |
| October 07, 2026 | 1.509 |
| October 06, 2026 | 1.616 |
| October 05, 2026 | 1.590 |
| October 02, 2026 | 1.608 |
| October 01, 2026 | 1.610 |
| September 30, 2026 | 1.641 |
| September 29, 2026 | 1.623 |
| September 28, 2026 | 1.630 |
| September 25, 2026 | 1.658 |
| September 24, 2026 | 1.625 |
| September 23, 2026 | 1.632 |
| September 22, 2026 | 1.719 |
| Date | Value |
|---|---|
| September 21, 2026 | 1.756 |
| September 18, 2026 | 1.720 |
| September 17, 2026 | 1.739 |
| September 16, 2026 | 1.682 |
| September 15, 2026 | 1.648 |
| September 14, 2026 | 1.683 |
| September 11, 2026 | 1.652 |
| September 10, 2026 | 1.718 |
| September 09, 2026 | 1.704 |
| September 08, 2026 | 1.705 |
| September 04, 2026 | 1.735 |
| September 03, 2026 | 1.686 |
| September 02, 2026 | 1.709 |
| September 01, 2026 | 1.768 |
| August 31, 2026 | 1.770 |
| August 28, 2026 | 1.813 |
| August 27, 2026 | 1.813 |
| August 26, 2026 | 1.822 |
| August 25, 2026 | 1.835 |
| August 24, 2026 | 1.816 |
| August 21, 2026 | 1.753 |
| August 20, 2026 | 1.753 |
| August 19, 2026 | 1.782 |
| August 18, 2026 | 1.749 |
| August 17, 2026 | 1.762 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 11.14 |
| ANI Pharmaceuticals, Inc. | 2.738 |
| Corcept Therapeutics, Inc. | 13.36 |
| Veru, Inc. | 1.382 |
| Avadel Pharmaceuticals Plc | -- |
Price to Book Value Related Metrics
| PE Ratio | 11.45 |
| PS Ratio | 2.660 |
| PEG Ratio | 1.055 |
| Price to Free Cash Flow | 9.329 |
| Price | 41.20 |
| Earnings Yield | 8.74% |
| Market Cap | 7.543B |
| PEGY Ratio | 0.7129 |
| Operating PE Ratio | 7.511 |
| Normalized PE Ratio | 11.44 |